Research ArticleBasic Science Investigations
Pharmacologic Intervention with Angiotensin II and Kininase Inhibitor Enhanced Efficacy of Radioimmunotherapy in Human Colon Cancer Xenografts
Seigo Kinuya, Kunihiko Yokoyama, Atsuhiro Kawashima, Takashi Hiramatsu, Shota Konishi, Noriyuki Shuke, Naoto Watanabe, Teruhiko Takayama, Takatoshi Michigishi and Norihisa Tonami
Journal of Nuclear Medicine July 2000, 41 (7) 1244-1249;
Seigo Kinuya
Kunihiko Yokoyama
Atsuhiro Kawashima
Takashi Hiramatsu
Shota Konishi
Noriyuki Shuke
Naoto Watanabe
Teruhiko Takayama
Takatoshi Michigishi


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Pharmacologic Intervention with Angiotensin II and Kininase Inhibitor Enhanced Efficacy of Radioimmunotherapy in Human Colon Cancer Xenografts
Seigo Kinuya, Kunihiko Yokoyama, Atsuhiro Kawashima, Takashi Hiramatsu, Shota Konishi, Noriyuki Shuke, Naoto Watanabe, Teruhiko Takayama, Takatoshi Michigishi, Norihisa Tonami
Journal of Nuclear Medicine Jul 2000, 41 (7) 1244-1249;
Pharmacologic Intervention with Angiotensin II and Kininase Inhibitor Enhanced Efficacy of Radioimmunotherapy in Human Colon Cancer Xenografts
Seigo Kinuya, Kunihiko Yokoyama, Atsuhiro Kawashima, Takashi Hiramatsu, Shota Konishi, Noriyuki Shuke, Naoto Watanabe, Teruhiko Takayama, Takatoshi Michigishi, Norihisa Tonami
Journal of Nuclear Medicine Jul 2000, 41 (7) 1244-1249;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Our ACE in the HOLE: Justifying the Use of Angiotensin-converting Enzyme Inhibitors as Adjuvants to Standard Chemotherapy
- Optimization of Radioimmunotherapy of Solid Tumors: Biological Impediments and Their Modulation
- Potentiation of Radioimmunotherapy with Response-Selective Peptide Agonist of Human C5a
- Methylxanthine Sensitization of Human Colon Cancer Cells to 186Re-Labeled Monoclonal Antibody